Princeton University has begun administering vaccinating against meningitis B. The vaccine being offered is not approved for use in the U.S. but the FDA and CDC both allowed its use for this particular outbreak at the school. Eight students at the campus have contracted the potentially fatal bacteria since March. Nearly 2,000 students received the vaccination on Monday, the first day it was available.
The outbreak at Princeton is helping raise awareness of what federal officials are calling super bugs. These are drug-resistant bacteria that are killing more people every year. One pharmaceutical company is making a big bet on what it hopes will be a new remedy to combat those super bugs.
Bertha Coombs reports.